Overview
Financials
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 6 days late).
- 202521/07/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Zumax dietary supplement
- Dietary supplements
- D-mannose
- Goldenrod extract
- Vitamin C
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
Trademarks
PM Pharma currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2025.
| Mark | Protected until | |
|---|---|---|
| ZUMAX(word) | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Olga Marciniakage 28 | 5 | $135.06 | 10% |
Piotr Marciniakage 52 | 45 | $1,215.56 | 90% |
The articles of association require board approval for share transfers.
Piotr Marciniak and Olga Marciniak hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-06-13.
54 1140 2004 0000 3102 8669 7877
77 1090 0088 0000 0001 5847 1703
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 6, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | –– | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Jul 7, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | –– | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Jun 2, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | –– | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Uropharmasp. z o.o. | $1,113,812.65 | uroplus.pl | ||
| Optiferricsp. z o.o. | $816,162.17 | optiferric.com | ||
| Human BiomeS.A. | $583,508.16 | human-biome.com | ||
| Hauster sp. z o.o.sp. k. | $577,912.26 | hauster.pl | ||
| PLON Pharmsp. z o.o. | $524,792.98 | plonpharm.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| Polmex Pharma Binieckisp. k. | $302,741.93 | polmex-pharma.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl |
FAQ
Last updated: 2026-10-05